Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abscess, intracerebral
acute disseminated encephalomyelitis
adverse drug reaction
Alzheimer's disease
Alzheimer's disease, diagnosis of
Alzheimer's disease, preclinical
amyloid beta protein
amyloid imaging
amyloid plaques
angiitis, isolated of CNS
anti MAG antibodies
antibodies to myelin basic protein
antimyelin antibodies
asymptomatic
ataxia
autoantibodies
autoimmune disease
axonal degeneration
axonal transection
B cell lymphocytes
Barkhof MR criteria for MS
BCG vaccination
BENEFIT study
biologic markers
brain atrophy
brain biopsy
brain volume
brainstem
brainstem, infarction of
brainstem, lesion of
carcinoma
carcinoma of breast
carotid artery occlusion, intracranial
CAT scan
CAT scan, abnormal
CAT scan, cerebrovascular disease
CAT scan, dense artery sign
CAT scan, early changes in CVA
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, mass effect on
CAT scan, ring sign
central nervous system, infection of
cerebellar infarction
cerebellar lesion
cerebral arteries
cerebral infarction
cerebral infarction, hemorrhagic
cerebral ischemia
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS disease
cerebrospinal fluid, oligoclonal IgG in
cerebrospinal fluid, protein of
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, arterial occlusion, location
cerebrovascular accident, prognosis in
cerebrovascular accident, recurrent
cerebrovascular accident, severity
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, volume
cerebrovascular accident, work up for
cerebrovascular accident, young adult
children
Clinical Pathologic Conference(C.P.C.)
cognition
complications
controversies in neurology
cop 1
corneal dystrophy
corpus callosum
corpus callosum, lesion of
cyclophosphamide
degenerative diseases of CNS
dementia
dementia, diagnostic evaluation of
dementia, early detection
dementia, presenile
dementia, rapidly progressive
dementia, screening for
demyelinating disease
diabetes insipidus
diagnostic criteria
differential diagnosis
disability rating scale, neurological
disability, neurological
disease modifying agents
efficacy
encephalitis
encephalitis, viral
encephalomyelitis, postinfectious
encephalopathy, Hashimoto's
encephalopathy, metabolic
endovascular therapy
enzyme, defect
Epstein-Barr virus
evoked potentials
Fabry's disease
falling
fever
fibrinolytic agents
fibrinolytic agents, complications
fingolimod
florbetapir
flu-like illness
fourth ventricle, shift of
fumarate
gadolinium
gait disorder
gammaglobulin therapy, intravenous
genetic neurologic disorders
head injury
hearing loss
hearing loss, sudden, unilateral
hemiparesis
heralding manifestation
herpes simplex encephalitis
herpes virus
herpes virus infection
hippocampal atrophy
hippocampus
hydrocephalus
hydrocephalus, exvacuo
hypertension
immunomodulation
immunosuppressive agents
immunotherapy
infection
interferon
interferon beta 1-a
interferon beta 1-b
internal carotid artery
intracerebral hemorrhage
intravenous
ischemic penumbra
Jakob-Creutzfeldt disease
laquinimod
L-dopa
leukoencephalopathy
leukopenia
liver function enzymes
lobar atrophy
Marburg's disease
McDonald criteria for MS
medulla oblongata, infarction of
memory, impairment of
mild cognitive impairment
misdiagnosis
mitoxantrone
monoclonal antibodies
MRI
MRI, abnormal
MRI, ADC maps
MRI, angiography
MRI, cerebrovascular disease
MRI, contrast enhanced
MRI, demyelinating disease
MRI, diffusion weighted
MRI, early changes in CVA
MRI, false negative
MRI, fast
MRI, field strength
MRI, field strength, high
MRI, functional
MRI, incidental finding
MRI, lesion burden
MRI, mass effect on
MRI, negative
MRI, optic nerve
MRI, perfusion
MRI, ring sign
MRI, serial
MRI, spinal cord
MRI, volumetry
MRS
multiple sclerosis
multiple sclerosis, acute
multiple sclerosis, asymptomatic
multiple sclerosis, children
multiple sclerosis, chronic progressive
multiple sclerosis, clinical patterns
multiple sclerosis, conversion to clinically definite
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, early onset
multiple sclerosis, etiology of
multiple sclerosis, misdiagnosis
multiple sclerosis, monosymptomatic
multiple sclerosis, MRI conversion
multiple sclerosis, MRI criteria
multiple sclerosis, pathogenesis
multiple sclerosis, preclinical
multiple sclerosis, presenting manifestations
multiple sclerosis, prognosis
multiple sclerosis, prophylaxsis
multiple sclerosis, radiologically isolated syndrome
multiple sclerosis, relapsing
multiple sclerosis, risk factors for
multiple sclerosis, secondary progressive
multiple sclerosis, spinal form
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
N-acetyl-L-aspartic acid
natalizumab
neoplasm, intracranial
neoplasm, primary intracerebral
neoplasm, primary intracranial
neoplasm, primary of CNS
neoplasm, primary of CNS-children
neurologic disease, diagnoses of
neurologic signs
neurologic symptoms
neuropathology
neuroprotective agents
neurosyphilis
NIH stroke scale
nystagmus
ocrelizumab
old age, neurology of
optic nerve, lesion of
optic neuritis
optic neuritis, bilateral
optic neuritis, children
optic neuritis, etiology of
optic neuritis, recurrent
optic neuritis, treatment of
optical coherence tomography
Parkinson disease
Parkinson disease, late onset
Parkinson disease, treatment of
Parkinson disease, young onset
periventricular leukomalacia
Pittsburgh Compound B
placebo
pons, infarction of
posterior cerebral artery territory infarction
posterior fossa
posterior fossa, lesion of
practice guidelines
preclinical
pregnancy, neurologic complications in
prevention of neurologic disorders
prion disease
prognosis
progressive neurologic disorder
protein 14-3-3, cerebrospinal fluid
pseudotumor
rapidly progressing neurologic illness
remote effect of cancer on the nervous system
revascularization, surgical
review article
risk factors
safety
sarcoidosis, CNS
screening
seizure
seizure, children
sensorineural hearing loss
serologic testing
single photon emission computed tomography
slurred speech
somnambulism
spinal cord
spinal cord, enlargement
spinal cord, intramedullary cyst of
spinal cord, lesion of
spinal cord, neoplasm
spinal cord, neoplasm, infants and children
steroid
steroid therapy, CNS treatment and complications with
stroke disability scale
symmetric brain lesions
symptomatic
syphilis, diagnosis and treatment
syphilis, neurologic complications with
syringomyelia
T lesion of MCA-ICA
temporal lobe, atrophy
thyroiditis
tinnitus
tissue plasminogen activator, intravenous
toxic encephalopathy
transient ischemic attack
treatment of neurologic disorder
uremia
urinary incontinence
urinary retention
ventricular enlargement
vertebral-basilar insufficiency
vertigo
vertigo, episodic
viral infection
viral infection, CNS
viral infection, reactivation
visual evoked response
West Nile fever
white matter disease
white matter disease, periventricular
Showing articles 1050 to 1100 of 4362 << Previous Next >>

Frequency of Anti-Nuclear Antibodies in Multiple Sclerosis
Neurol 45:384-385, Barned,S.,et al, 1995

Low-Dose (7. 5mg) Oral Methotrexate Reduces the Rate of Progression in Chronic Progressive Multiple Sclerosis
Ann Nuerol 37:30-40, 51995., Goodkin,D.E.,et al, 1995

Decreased Hippocampal Volume Asymmetry on MRIs in Nondemented Elderly Subjects Carrying the Apolipoprotein E-4 Allele
Neurol 45:391-392, Soininen,H.,et al, 1995

Neurologic Aspects of Inflammatory Bowel Disease
Neurol 45:416-421, Lossos,A.,et al, 1995

Bilateral Simultaneous Optic Neuropathy in Adults:Clinical, Imaging, Serological, and Genetic Studies
JNNP 58:70-74, Morrissey,S.P.,et al, 1995

Optic Neuritis:A Population-Based Study in Olmsted County, Minnesota
Neurol 45:244-250, Rodriquez,M.,et al, 1995

Acute Viral Encephalitis in Childhood
BMJ 310:139-140, Kennedy,C., 1995

Tourette's Syndrome:A Model Neuropsychiatric Disorder
JAMA 273:498-501, Hyde,T.M.&Weinberger,D.R., 1995

Neurodevelopmental Outcome of Infants with Hypoplastic Left Heart Syndrome
J Pediatr 126:496-498, Rogers,B.T.,et al, 1995

The Effect of Gadolinium on the Sensitivity and Specificity of MR in the Initial Diagnosis of Multiple Sclerosis
AJNR 16:259-264, Tas,M.W.,et al, 1995

Correlation Between Changes in Disability and T2-Weighted Brain MRI Activity in Multiple Sclerosis:A Follow-up Study
Neurol 45:255-260, Filippi,M.,et al, 1995

Acute Transverse Myelopathy:Spinal and Cranial MR Study with Clinical Follow-up
AJNR 16:115-123, Campi,A.,et al, 1995

Investigation of Peripheral Neuropathy
JNNP 58:274-283, McLeod,J.G., 1995

Focal Leptomeningeal MR Enhancement Along the Chiasm as a Presenting Sign of Multiple Sclerosis
J Comput Assist Tomogr 19:297-298, Demaerel,Ph.,et al, 1995

Identification of Comatose Patients at High Risk for Death or Severe Disability
JAMA 273:1842-1848, Hamel,M.B.,et al, 1995

Neurofibromatosis 1 and Multiple Sclerosis
JNNP 58:582-585, Ferner,R.E.,et al, 1995

Multiphasic Disseminated Encephalomyelitis Presenting as Alternating Hemiplegia
JNNP 58:467-470, Khan,S.,et al, 1995

Multiple Sclerosis in the Spinal Cord, MR Appearance and Correlation with Clinical Parameters
Radiology 195:725-732, Tartaglino,L.M.,et al, 1995

Interferon Beta-1b in the Trtm of MS:Outcome of the Randomized Controlled Trial
IFNB Study Gr, Neurol 45:1277-12851995., , 1995

Effect of Interferon-B on Blood-Brain Barrier Disrupt Demonst by Contrast MRI in Relapsing-Remitting MS
Ann Neurol 37:611-619, Stone,L.A.,et al, 1995

Copolymer 1 Reduces Relapse Rate & Improves Disability in Relapsing-Remitting MS:Multictr Trial
Neurol 45:1268-1276, Johnson,K.P.,et al, 1995

Trigeminal Neuralgia in Multiple Sclerosis
Neurol 45:1294-1296, Hooge,J.P.&Redekop,W.K., 1995

Association Between Trigeminal Neuralgia and Multiple Sclerosis:Role of Magnetic Resonance Imaging
JNNP 59:253-259, Meaney,J.F.M.,et al, 1995

Patients with Multiple Sclerosis Presenting to Psychiatric Hospitals
J Clin Psychiatry 56:297-306, Pine,D.S.,et al, 1995

Spinal Multiple Sclerosis Mimicking a Spinal Cord Tumor:A Case Report
Neurological Surgery 23:1007-1010, Maezawa,H.,et al, 1995

Quantitative Hippocampal MRI and Intractable Temporal Lobe Epilepsy
Neurol 45:2233-2240, vanPaesschen,W.,et al, 1995

Comparison of Triple Dose vs Std Dose Gadolinium-DTPA for Detect of MRI Enhanc Lesions in Pts with Primary Progr MS
JNNP 59:540-544, Filippi,M.,et al, 1995

Multifocal Demyelinating Motor Neuropathy:Pathologic Evidence of Inflammatory Demyelinasting Polyradiculoneuropathy
Neurol 45:1828-1832, Oh,S.J.,et al, 1995

Decreased SPECT[123I]B-CIT Striatal Uptake Correlates with Symptom Severity in Parkinson's Disease
Ann Neurol 38:589-598, Seibyl,J.P.,et al, 1995

Hereditary Adult-Onset Alexander's Disease with Palatal Myoclonus, Spastic Paraparesis and Cerebellar Ataxia
Neurol 45:2266-2271, Schwankhaus,J.D.,et al, 1995

Magnetic Resonance Imaging of Brain Iron in Health and Disease
J Neurol Sci 134:19-26,1, Vymazal,J.,et al, 1995

Posttraumatic Headache
Semin Neurol 14:40-45, Packard,R.C., 1994

Mild Head Injury
(Ed) , Semin Neurol 14:1-9294., Packard,R.C., 1994

Regional Brain Abnormalities in Schizophrenia Measured with Magnetic Resonance Imaging
JAMA 272:1763-1769, Andreasen,N.C.,et al, 1994

Longitudinal MRI in Multiple Sclerosis:Correlation Between Disability and Lesion Burden
Neurol 44:2120-2124, Khoury,S.J.,et al, 1994

Growth Factors:Potential Therapeutic Applications in Neurology
JNNP 54:1445-1450, Drago,J.,et al, 1994

Tizanidine Treatment of Spasticity Caused by Multiple Sclerosis:Results of a Double-Blinded, Placebo-Controlled Trial
Neurol 44:S34-S43, Smith,C.,et al, 1994

A Double-Blind, Placebo-Controlled Trial of Tizanidine in the Treatment of Spasticity Caused by Multiple Sclerosis
Neurol 44:S70-S78, Barnes,M.P.,et al, 1994

A Brief History of the Use of Interferons as Treatment of Multiple Sclerosis
Arch Neurol 51:1245-1252, Jacobs,L.&Johnson,K.P., 1994

The Hidden Costs of Medicolegal Abuses in Neurology
Arch Neurol 51:650-652, Scheinberg,P., 1994

Neuroanatomy of Fragile X Syndrome:The Temporal Lobe
Neurol 44:1317-1324, Reiss,A.L.,et al, 1994

Reduced Basal Ganglia Volume Associated with the Gene for Huntington's Disease in Asymptomatic at-Risk Persons
Neurol 44:823-828, Aylward,E.H.,et al, 1994

The Use of Brain Magnetic Resonance Imaging in Multiple Sclerosis
Arch Neurol 51:505-516, Goodkin,D.E.,et al, 1994

Benign Form of Multiple Sclerosis:MRI Evidence for Less Frequent and Less Inflammatory Disease Activity
JNNP 57:1070-1072, Kidd,D.,et al, 1994

Quantitative Brain MRI Lesion Load Predicts the Course of Clinically Isolated Syndromes Suggestive of Multiple Sclerosis
Neurol 44:635-641, Felippi,M.,et al, 1994

Extent of Pontine Pyramidal Tract Wallerian Degeneration and Outcome after Supratentorial Hemorrhagic Stroke
Stroke 25:1207-1210, Fukui,K.,et al, 1994

MR of Sarcoidosis in the Head and Spine:Spectrum of Manifestations and Radiographic Response to Steroid Therapy
AJNR 15:973-982, Lexa,F.J.&Grossman,R.I., 1994

Orbital and Optic Pathway Sarcoidosis:MR Findings
AJNR 15:775-783, Carmody,R.F.,et al, 1994

Antiphospholipid Antibody Syndrome Mimicking Multiple Sclerosis Clinically and by Magnetic Resonance Imaging
Arch Int Med 154:917-920, Scott,T.F.,et al, 1994

Leber's Hereditary Optic Neuropathy Mitochondrial DNA Mutations in Multiple Sclerosis
Ann Neurol 36:109-112, Kellar-Wood,H.,et al, 1994



Showing articles 1050 to 1100 of 4362 << Previous Next >>